Hyperfine, Inc. (HYPR) stock
HYPRNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3028% below fair value
$0.54−0.02 (-2.97%)
Close on Nov 18, 2026Market cap $57.79MP/E –Yield –
Hyperfine net income
Net income is the profit left for shareholders after every expense, interest and tax.
Hyperfine's net income for the twelve months ending Jun 30, 2026 was -$34.85M. For fiscal 2025 it was -$35.57M. The highest annual figure on record is -$23.43M in fiscal 2020.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$35.57M | – |
| FY2024 | Dec 31, 2024 | -$40.72M | – |
| FY2023 | Dec 31, 2023 | -$44.24M | – |
| FY2022 | Dec 31, 2022 | -$44.24M | – |
| FY2021 | Dec 31, 2021 | -$64.85M | – |
| FY2020 | Dec 31, 2020 | -$23.43M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$9.30M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.62M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.91M | – |
| Q3 FY2025 | Sep 30, 2025 | -$11.02M | – |
| Q2 FY2025 | Jun 30, 2025 | -$9.23M | – |
| Q1 FY2025 | Mar 31, 2025 | -$9.42M | – |
| Q4 FY2024 | Dec 31, 2024 | -$10.39M | – |
| Q3 FY2024 | Sep 30, 2024 | -$10.33M | – |
| Q2 FY2024 | Jun 30, 2024 | -$10.16M | – |
| Q1 FY2024 | Mar 31, 2024 | -$9.85M | – |
| Q4 FY2023 | Dec 31, 2023 | -$10.68M | -167.3% |
| Q3 FY2023 | Sep 30, 2023 | -$10.76M | – |
| Q2 FY2023 | Jun 30, 2023 | -$10.64M | – |
| Q1 FY2023 | Mar 31, 2023 | -$12.16M | – |
| Q4 FY2022 | Dec 31, 2022 | $15.87M | – |
| Q3 FY2022 | Sep 30, 2022 | -$13.17M | – |
| Q2 FY2022 | Jun 30, 2022 | -$23.16M | – |
| Q1 FY2022 | Mar 31, 2022 | -$23.78M | – |
| Q4 FY2021 | Dec 31, 2021 | -$26.09M | – |
| Q3 FY2021 | Sep 30, 2021 | -$16.39M | – |
| Q2 FY2021 | Jun 30, 2021 | -$14.58M | – |
| Q1 FY2021 | Mar 31, 2021 | -$7.79M | – |
See a number that looks wrong?